Veterinary Medicines

CANVAC 8 DHPPiL lyofilizát na prípravu injekčnej suspenzie s rozpúšťadlom pre psov

Authorised
  • Leptospira interrogans, serogroup Sejroe, Inactivated
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Download as PDF

Product identification

Medicine name:
CANVAC 8 DHPPiL lyofilizát na prípravu injekčnej suspenzie s rozpúšťadlom pre psov
Active substance:
  • Leptospira interrogans, serogroup Sejroe, Inactivated
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Sejroe, Inactivated
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
  • Canine parainfluenza virus, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, Live
    2.10
    haemagglutinating units
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, Live
    3.50
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine distemper virus, Live
    2.70
    log 10 50% embryo infective dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dyntec spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dyntec spol. s r.o.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/0296/96-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 24/01/2022
Download